[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate

C27H36N2O5 — CID 10766689

IUPAC[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate
SMILESCC1=CC[C@H](C(C)C)[C@H]2/C=C(/CO)[C@@]3(O)C=C[C@](C)(O3)[C@@H](OC(=O)/C=C/c3cn(C)cn3)C[C@@H]12
InChIInChI=1S/C27H36N2O5/c1-17(2)21-8-6-18(3)22-13-24(33-25(31)9-7-20-14-29(5)16-28-20)26(4)10-11-27(32,34-26)19(15-30)12-23(21)22/h6-7,9-12,14,16-17,21-24,30,32H,8,13,15H2,1-5H3/b9-7+,19-12-/t21-,22+,23-,24+,26+,27-/m1/s1
InChIKeyMMOHACKIWUXFNF-IDDQVFIJSA-N
MW468.59 g/mol
LogP3.56
Rot. Bonds5

About [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate

[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate (PubChem CID 10766689) has the molecular formula C27H36N2O5 and a molecular weight of 468.59 g/mol. Its IUPAC name is [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate.

Molecular Properties

Compound Name[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate
PubChem CID10766689
Molecular FormulaC27H36N2O5
Molecular Weight468.59 g/mol
Exact Mass468.26
IUPAC Name[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate
SMILESCC1=CC[C@H](C(C)C)[C@H]2/C=C(/CO)[C@@]3(O)C=C[C@](C)(O3)[C@@H](OC(=O)/C=C/c3cn(C)cn3)C[C@@H]12
InChIInChI=1S/C27H36N2O5/c1-17(2)21-8-6-18(3)22-13-24(33-25(31)9-7-20-14-29(5)16-28-20)26(4)10-11-27(32,34-26)19(15-30)12-23(21)22/h6-7,9-12,14,16-17,21-24,30,32H,8,13,15H2,1-5H3/b9-7+,19-12-/t21-,22+,23-,24+,26+,27-/m1/s1
InChIKeyMMOHACKIWUXFNF-IDDQVFIJSA-N
XLogP3.56
TPSA93.81 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500468.59
LogP ≤ 53.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate?
The IUPAC name of [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate (CID 10766689) is [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate.
What is the SMILES notation for [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate?
The canonical SMILES for [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate is CC1=CC[C@H](C(C)C)[C@H]2/C=C(/CO)[C@@]3(O)C=C[C@](C)(O3)[C@@H](OC(=O)/C=C/c3cn(C)cn3)C[C@@H]12.
What is the InChIKey of [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate?
The InChIKey is MMOHACKIWUXFNF-IDDQVFIJSA-N. The full InChI is InChI=1S/C27H36N2O5/c1-17(2)21-8-6-18(3)22-13-24(33-25(31)9-7-20-14-29(5)16-28-20)26(4)10-11-27(32,34-26)19(15-30)12-23(21)22/h6-7,9-12,14,16-17,21-24,30,32H,8,13,15H2,1-5H3/b9-7+,19-12-/t21-,22+,23-,24+,26+,27-/m1/s1.
What are the key properties of [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate?
[(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate has a molecular weight of 468.59 g/mol, XLogP of 3.56, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,2S,4R,8R,9S,10Z,12R)-12-hydroxy-11-(hydroxymethyl)-1,5-dimethyl-8-propan-2-yl-15-oxatricyclo[10.2.1.04,9]pentadeca-5,10,13-trien-2-yl] (E)-3-(1-methylimidazol-4-yl)prop-2-enoate is sourced from PubChem (CID 10766689), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).